Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

INVO Fertility (IVF) Cost of Revenue (2016 - 2025)

INVO Fertility has reported Cost of Revenue over the past 15 years, most recently at $1.1 million for Q3 2025.

  • Quarterly Cost of Revenue rose 14.09% to $1.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Sep 2025, up 19.41% year-over-year, with the annual reading at $3.7 million for FY2024, 92.16% up from the prior year.
  • Cost of Revenue was $1.1 million for Q3 2025 at INVO Fertility, up from $1.1 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $1.1 million in Q3 2025 and troughed at $12163.0 in Q2 2021.
  • The 5-year median for Cost of Revenue is $235714.0 (2023), against an average of $495183.9.
  • The largest YoY upside for Cost of Revenue was 11440.8% in 2021 against a maximum downside of 35.09% in 2021.
  • A 5-year view of Cost of Revenue shows it stood at $54588.0 in 2021, then surged by 105.34% to $112093.0 in 2022, then soared by 691.08% to $886750.0 in 2023, then grew by 14.68% to $1.0 million in 2024, then rose by 10.9% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Cost of Revenue are $1.1 million (Q3 2025), $1.1 million (Q2 2025), and $1.0 million (Q1 2025).